AOH holders aren't too far away from having a 50% reduction in what they got their new shares for. the future aside. that shows they got screwed on a opportunistic deal.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game